Phase II Trial of Sorafenib in Combination With Modified FOLFOX in Patients With Advanced Hepatocellular Carcinoma
Latest Information Update: 23 Apr 2020
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Biomarker; Therapeutic Use
- 21 Apr 2020 Status changed from active, no longer recruiting to completed.
- 06 Sep 2018 Results published in the Clinical Cancer Research
- 08 Aug 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.